Accretion Nutraveda Ltd (544694)
Latest quarterly results (H2 FY26)
In its latest reported quarter, H2 FY26, Accretion Nutraveda's revenue was ₹19.5 Cr (+80.1% year on year, +39.0% on the previous half-year), and net profit ₹2.7 Cr (+56.4% year on year); the operating margin was 18.2%.
| H2 FY26 (₹ Cr) | Value | YoY vs H2 FY25 | vs prev. half |
|---|---|---|---|
| Revenue | ₹19.5 | +80.1% | +39.0% |
| Operating profit | ₹3.6 | +38.0% | +7.9% |
| Net profit | ₹2.7 | +56.4% | +15.5% |
| EPS (₹) | 3.72 | -89.5% | -15.1% |
| Operating margin | 18.2% | — | — |
📢 Recent Corporate Announcements
Accretion Nutraveda has announced its 5th Annual General Meeting (AGM) for August 27, 2026, to be held via video conferencing. The company has released the full Annual Report for FY 2025-26, a period where revenue grew 110% to ₹33.6 Cr from ₹16.0 Cr in the previous year. This filing is a procedural requirement to ensure shareholders can access the report and notice of the meeting. The company reported a net profit of ₹5.07 Cr for FY26 with an operating margin of 20.51%.
- 5th Annual General Meeting scheduled for August 27, 2026, at 02:00 PM IST
- FY26 Annual Report released showing revenue of ₹33.6 Cr
- Net profit for FY26 stood at ₹5.07 Cr with an EPS of ₹7.0
- Operating Profit Margin (OPM) for FY26 recorded at 20.51%
Accretion Nutraveda has issued a notice for its 5th Annual General Meeting (AGM) to be held on August 27, 2026. The agenda includes the appointment of two new Independent Directors and a significant revision in remuneration for six key directors, including the Managing Director and CFO. The proposed salary cap is set at ₹5,00,000 per month for each of the six directors. If fully utilized, the total annual salary outlay of ₹3.6 crore would represent approximately 71% of the company's FY26 net profit of ₹5.07 crore.
- AGM scheduled for August 27, 2026, to adopt FY26 financial statements.
- Proposed salary revision for 6 directors to a maximum of ₹5,00,000 per month each.
- Appointment of Mr. Chand Rameshbhai Kanabar and Ms. Grishma A Shewale as Independent Directors for 5-year terms.
- Company reported FY26 revenue of ₹33.6 crore, a 110% increase from FY25 revenue of ₹16.0 crore.
- Total potential annual management salary cap of ₹3.6 crore vs FY26 Net Profit of ₹5.07 crore.
Accretion Nutraveda Ltd has released its Annual Report for FY 2025-26 and scheduled its 5th Annual General Meeting (AGM) for August 27, 2026. The company reported a significant revenue jump to ₹33.6 crore in FY26 from ₹16.0 crore in FY25, representing 110% growth. Net profit for the year stood at ₹5.07 crore with a healthy ROCE of 27.6%. The report details the company's transition to a public limited entity on May 2, 2025, and its focus on Ayurvedic and Nutraceutical formulations.
- FY26 Revenue grew 110% year-on-year to ₹33.6 crore compared to ₹16.0 crore in FY25
- Net Profit for FY26 reached ₹5.07 crore with an Operating Profit Margin (OPM) of 20.51%
- 5th Annual General Meeting scheduled for August 27, 2026, at 02:00 P.M. via Video Conferencing
- Remote e-voting period set from August 24, 2026, to August 26, 2026, with a cut-off date of August 20, 2026
- Company maintained a low Debt-to-Equity ratio of 0.12 with total debt of ₹4 crore against a net worth of ₹35 crore
Financial Performance
Financial analysis data not yet available for this company.
Operational Drivers
Operational analysis data not yet available for this company.
Strategic Growth
Strategic growth analysis not yet available for this company.
External Factors
External factors analysis not yet available for this company.
Regulatory & Governance
Regulatory analysis not yet available for this company.
Risk Analysis
Risk analysis not yet available for this company.
